[Federal Register Volume 68, Number 125 (Monday, June 30, 2003)]
[Notices]
[Page 38711]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-16407]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Applied Research on Antimicrobial Resistance 
Prevention, Program Announcement 03120

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Applied Research on Antimicrobial 
Resistance, Program Announcement 03120.
    Times and Dates: 9 a.m.-10 a.m., July 17, 2003 (Open), 10 a.m.-6 
p.m., July 17, 2003 (Closed).
    Place: National Center for Infectious Disease, Office of the 
Director, OAS Conference Room 3555, 35 Executive Park 
Drive, Atlanta, GA 30342, Telephone 404.498.3240.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c) (4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement 03120.
    Contact Person for More Information: Mary L. Lerchen, Deputy 
Director, Office of Extramural Research, National Center for 
Infectious Diseases, CDC, 1600 Clifton Road, MS-C19, Atlanta, GA 
30333, Telephone 404.639.0043.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 20, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 03-16407 Filed 6-27-03; 8:45 am]
BILLING CODE 4163-18-P